Quantcast
Last updated on April 17, 2014 at 1:21 EDT

Latest colitis Stories

2010-12-06 23:13:40

An international team of researchers led by the University of East Anglia (UEA) have developed a new kind of endoscope to aid the early detection and diagnosis of inflammatory bowel disease. The Confocal Laser Endomicroscope (CLE) contains a powerful microscope which allows clinicians to view the bacteria that are thought to trigger diseases of the bowel such as Crohn's disease and ulcerative colitis. "Bacteria within the wall of the gut are already believed to play an important role in the...

2010-12-02 00:51:39

Findings identify potential strategies for treating inflammatory bowel diseases A new study involving a man who swallowed worm eggs to relieve symptoms of ulcerative colitis sheds light on how worms promote healing in the intestine. The study, published today in Science Translational Medicine, also identifies potential targets for more conventional ways of treating colitis, an inflammatory bowel disease. "The idea for treating colitis with worms is not new, but how this therapy might work...

2010-11-30 06:15:00

OAKLAND, Calif., Nov. 30, 2010 /PRNewswire-USNewswire/ -- The Kenneth Rainin Foundation announced today its 2011 Innovator Awards Program for Inflammatory Bowel Disease. The Program, now in its second year, is designed to accelerate the pace of discovery in IBD research. Approximately four million people worldwide suffer from some form of IBD. Although the disease can occur at any age, the peak onset is between the ages of 15 to 30. Approximately 10% of the cases occur in children,...

2010-11-29 06:30:00

CLEVELAND, Nov. 29, 2010 /PRNewswire-FirstCall/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today publically congratulated its sponsor partner Cosmo Pharmaceuticals S.p.A. (SIX: COPN) who last week announced positive top-line results from their second pivotal Phase III clinical study which was conducted in the EU utilizing DATATRAK's unified eClinical product suite and services team...

2010-11-22 19:10:17

A sugar found in mouse breast milk promotes the generation of colitis in offspring, according to a study published online on November 22 in the Journal of Experimental Medicine (www.jem.org). Sugars in breast milk are essential for the development of the newborn immune system and the growth of beneficial commensal bacteria in the gut. But certain milk sugars in certain contexts could be bad news. A group led by Thierry Hennet at the University of Zurich found that newborn mice fostered by...

2010-11-15 08:30:00

New interactive components lead to better Crohn's disease and ulcerative colitis education and disease management NEW YORK, Nov. 15, 2010 /PRNewswire-USNewswire/ -- The Crohn's & Colitis Foundation of America today announced the launch of new enhancements and resources to its online community (www.ccfacommunity.org). Developed to meet the dynamic needs of patient groups, this site serves as a free resource to provide patients and families with the vital peer support they need in...

2010-11-01 21:29:07

Helicobacter pylori in the mouse stomach put the brakes on colitis by reducing the immune response in the lower GI tract, U-M study shows Helicobacter pylori, a common stomach bacterium, reduced the severity of inflammation of the colon caused by Salmonella in mice, according to research from U-M Medical School scientists. More than half the people in the world are infected with H. pylori, although it is very unusual to find it in the United States. But this research shows there may be an...

2010-11-01 02:00:00

WOLLERAU, Switzerland, November 1, 2010 /PRNewswire/ -- - AOP Orphan to Make Strategic EUR3m Investment in Shield Holdings Shield Holdings AG (Shield), the independent specialty pharmaceutical company focused on the development and commercialisation of late-stage hospital pharmaceuticals, today announces that it has signed a strategic commercialisation agreement for its lead asset, ST10-021, an iron therapy product which has commenced Phase III clinical development, with AOP...

2010-10-27 06:30:00

MOUNTAIN VIEW, Calif., Oct. 27 /PRNewswire/ -- ChemoCentryx, Inc., today announced that it reported one-year results from the Company's PROTECT-1 Study (the Prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial) of Traficet-EN(TM) (CCX282-B) in patients with moderate-to-severe Crohn's disease. Traficet-EN, an orally bioavailable CCR9-specific chemokine receptor antagonist showed clinical efficacy in a 12-week Induction period, as well as a 36-week Maintenance period....

2010-10-21 00:00:42

The Crohn's & Colitis Foundation today announced that Bob Van Dillen, meteorologist for HLN's "Morning Express with Robin Meade," will again serve as honorary Chairman of its endurance training and fundraising program, Team Challenge (http://www.ccteamchallenge.org). As Honorary Chairman, Van Dillen is training for the December 5th Zappos.com Rock "Ëœn' Roll Las Vegas Half Marathon and raising crucial dollars for the Foundation's research, education, and support services. New...


Latest colitis Reference Libraries

0_9f897835bb09adc2a84fda23893d87f8
2011-04-15 13:50:01

Clostridium difficile, also known as "CDF/cdf", or "C. diff", is a Gram-positive bacteria of the genus Clostridium that causes severe diarrhea and other intestinal disease when competing bacteria in the gut flora are wiped out by antibiotics. They are anaerobic, spore-forming rods and is the most serious cause of antibiotic-associated diarrhea and potentially to pseudomembranous colitis. C. difficile bacteria naturally resides in the gut of a small percentage of the adult population. Others...

More Articles (1 articles) »